Drug marketers should appeal to reason during recession

Share this article:
Marketers must appeal less to the emotions and more to ration to woo consumers amid the economic downturn, according to a DDB study. 

“Consumers are not going to be as motivated to take action based solely on higher-order/emotional end benefits in the pharmaceutical, or even in the well—being space,” said Maria Tender, DDB director of brand planning. “Today, more than ever, they will need tangible benefits ascribed to certain brands.”

The survey, by Omnicom's DDB and M/A/R/C Research, found that the value consumers place on health and the time they spend thinking about it increase as incomes dwindle.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Headliner: Ipsen head leads continental charge

Headliner: Ipsen head leads continental charge

"When I look at the business, I actually see patients in my mind. I don't see numbers."

Read the complete October 2014 Digital Edition

Read the complete October 2014 Digital Edition

Click the above link to access the complete Digital Edition of the October 2014 issue of MM&M, with all text, charts and pictures.

Predicting your pink slip

Predicting your pink slip

Any time a firm needs to save money, high-salaried executives are targets